Karolinska accredited as “Center of Excellence” for ovarian cancer


The European Society of Gynaecological Oncology (ESGO) has accredited gynecological cancer at Karolinska as a Center of Excellence, the highest level it awards.

"This accreditation means that we are now one of about ten hospitals in Europe and the first in Sweden to receive this designation, so naturally we are extremely pleased. I'm proud of all of our employees, whose high professionalism and quality of care have met the extensive requirements and criteria necessary for this accreditation," says Henrik Falconer, Head of Patient Flow, at Karolinska University Hospital.

In Sweden, about 700 women are diagnosed with ovarian cancer each year. The average age of these patients is about 70. Many are diagnosed at late stage and the prognosis for 5-year survival is about 50 percent. While waiting for improved early detection, surgical expertise is the most important prognostic factor.

Read here for more information about ESGO